Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest AIDS Stories

2014-04-03 12:58:10

New research suggests that drugs commonly used to prevent organ rejection after transplantation may also be helpful for combating HIV. The findings, which are published in the American Journal of Transplantation, suggest a new strategy in the fight against HIV and AIDS. Despite the effectiveness of antiviral therapies at suppressing HIV, the virus still persists indefinitely at low levels in infected patients who are diligent about taking their medications. "Current therapies fail to cure...

2014-04-02 23:32:49

Presentation details three separate tuberculosis immunotherapies developed by Immunitor in collaboration with academic institutions and private companies in Mongolia, China, Thailand, Ukraine, UK, USA and Canada. Data presented support the Immunitor strategy to target inflammation as the main cause of TB and development of immunomodulators and therapeutic vaccines which demonstrate ability to rapidly clear TB, including MDR-TB and TB with HIV. Vancouver, BC, Canada (PRWEB) April 02, 2014...

2014-04-02 20:22:23

LOS ANGELES, April 2, 2014 /PRNewswire-USNewswire/ -- On March 19 the Centers for Disease Control and Prevention (CDC) awarded $115 million over five years to 21 organizations to provide technical assistance to health departments and organizations implementing CDC's new prevention strategies and improving health outcomes for people living with HIV/AIDS. Not one of these organizations is a Black organization. The effect of this decision is that Black organizations have been locked out...

2014-04-01 16:25:28

Elizabeth Glaser Pediatric AIDS Foundation Applauds Agreement between the Medicines Patent Pool and ViiV Healthcare WASHINGTON, April 1, 2014 /PRNewswire-USNewswire/ -- The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) applauds the licensing agreement between the Medicines Patent Pool (MPP) and ViiV Healthcare to increase access to dolutegravir (DTG), a promising new antiretroviral (ARV) medication. This agreement will allow generic manufacturers to scale up production of...

2014-04-01 16:25:22

GENEVA, April 1, 2014 /PRNewswire/ -- Access to dolutegravir could improve millions of lives in developing countries The Medicines Patent Pool (MPP) and ViiV Healthcare announced a new collaboration on HIV medicines today, signing two licensing agreements to increase access to dolutegravir (DTG), a promising new antiretroviral, for both adult and paediatric care. The agreements would allow generic...

2014-04-01 16:25:15

- Timely collaborations underscore ViiV Healthcare's commitment to increase access to life-saving HIV medicines for children and adults in the developing world LONDON, April 1, 2014 /PRNewswire/ -- ViiV Healthcare today announced new collaborations with the goal of increasing access to its HIV medicine, dolutegravir (marketed under the name Tivicay®), just two months after its approval by the European Medicines Agency (EMA) and eight months after approval by the US Food and Drug...

2014-04-01 14:04:36

Pressure from counselors and perceived ineffectiveness & irrelevance of intervention keep young adults from returning to follow-up sessions Keeping young people in human immunodeficiency virus (HIV) prevention programs is a major goal in reducing the incidence of HIV, and multi-session interventions are often more effective than single-sessions. But according to a new study from the Annenberg School for Communication, the way these programs are designed and implemented may turn off the...

2014-04-01 12:56:08

Men with long-term HIV infections are at higher risk than uninfected men of developing plaque in their coronary arteries, regardless of their other risk factors for coronary artery disease, according to results of a study led by Johns Hopkins researchers. A report on the research appears in the April 1 issue of Annals of Internal Medicine. The finding is important, investigators say, because advances in treatment have led to long-term survival of people living with HIV/AIDS and the...

2014-03-31 20:21:42

DUBLIN, April 1, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/hnfpj3/hiv_vaccine) has announced the addition of the "HIV Vaccine Market Opportunity & Clinical Pipeline Analysis" [http://www.researchandmarkets.com/research/hnfpj3/hiv_vaccine ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Ever since HIV was identified as the cause for AIDS 30 years ago, the HIV virus has become...

2014-03-27 08:35:14

PITTSBURGH, March 27, 2014 /PRNewswire/ -- PANTHERx Specialty Pharmacy announced today that it has been awarded the exclusive contract to serve as the specialty pharmacy provider for the South Carolina AIDS Drug Assistance Program (SC ADAP) Direct Dispensing service tier, effective June 1, 2014. Logo - http://photos.prnewswire.com/prnh/20140327/NE91471LOGO As an ADAP provider, PANTHERx Specialty, one of the nation's fastest growing specialty pharmacies, will help to facilitate...


Latest AIDS Reference Libraries

AIDS
2012-05-07 07:38:24

AIDS is a peer-reviewed scientific journal published 18 times yearly by Lippincott Williams & Wilkins, London, UK. It was established in 1987 and is the official journal of the International AIDS Society. It covers all aspects of HIV and AIDS research, including basic science, clinical trials, epidemiology, and social science. As of May 2012, the editor-in-chief is Jay A. Levy. AIDS has been cited as the most read journal in its area of science and has the highest impact of all...

70_dd0fb65b7366091c1e0897e58f1798fa
2011-02-23 20:58:48

Simian immunodeficiency virus (SIV), also known as African Green Monkey virus, is a retrovirus able to infect at least 33 species of African primates. SIV has been present in monkeys and apes for at least 32,000 years, probably longer. Strains from two of these primate species have crossed the barriers into humans resulting in HIV-2 and HIV-1. Contraction involves contact with the blood of chimps that are often hunted for bushmeat in Africa. SIV infections appear in many cases to be...

0_336928514f8c16d00d00e956be85245d
2011-02-17 15:06:48

Kaposi's sarcoma-associated herpesvirus (KSHV) one of seven currently known human cancer virus, is also the eighth human herpesvirus. Kaposi's sarcoma, caused by the virus, is common in AIDS patients, primary effusion lymphoma, and some types of multicentric Castelman's disease. Moritz Kaposi discovered the blood vessel tumor, in 1872, which would eventually be names Kaposi's sarcoma. It was originally though that KS was of Jewish and Mediterranean origins until it was found to be common...

0_a4499f7c8759b5cbe79bad5eca319070
2011-01-26 14:08:59

Human immunodeficiency virus (HIV), a lentivirus, causes acquired immunodeficiency syndrome (AIDS) which is a condition in humans were the immune system begins to fail, leading to life-threatening opportunistic infections. Infection is transferred through bodily fluids where HIV is present as both free virus particles and within infected immune cells. The four most common routes of infection are unsafe sex, contaminated needles, breast milk, and transmission from an infected mother to her...

More Articles (4 articles) »